Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.

Abstract

Elderly patients constitute a large and growing proportion of ST-elevation myocardial infarction (STEMI) patients, yet they have been under-represented or even excluded from reperfusion trials. Despite evidence that fibrinolysis improves outcomes irrespective of age, many elderly STEMI patients still remain undertreated or subject to major delays to primary… (More)
DOI: 10.1007/s40266-016-0345-6

Topics

3 Figures and Tables

Cite this paper

@article{Sinnaeve2016DrugTO, title={Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.}, author={Peter R. Sinnaeve and Thierry Danays and Kris Bogaerts and Frans J J Van De Werf and P Armstrong}, journal={Drugs & aging}, year={2016}, volume={33 2}, pages={109-18} }